| Literature DB >> 17490884 |
Jason Xiang1, Manus Ipek, Vipin Suri, May Tam, Yuzhe Xing, Nelson Huang, Yanling Zhang, James Tobin, Tarek S Mansour, John McKew.
Abstract
The design, synthesis, and biological evaluation of beta-keto sulfones as 11beta-HSD1 inhibitors and the mechanism of inhibition are described here. This class of compounds is not active against 11beta-HSD2 and therefore may have therapeutic potential for metabolic syndrome and type 2 diabetes.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17490884 DOI: 10.1016/j.bmc.2007.04.035
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641